INSTRUMENTATION GRANTS FOR IMAGING EQUIPMENT USED IN CLINICAL TRIALS:
ADMINISTRATIVE SUPPLEMENTS TO CANCER CENTER SUPPORT GRANTS (P30)
 
RELEASE DATE:  April 11, 2003

NOTICE:  NOT-CA-03-026

National Cancer Institute (NCI)
 (http://www.nci.nih.gov/)

The National Cancer Institute (NCI) is announcing the availability of 
administrative supplemental funds for NCI-funded cancer center grantees 
(P30s) (domestic only). The primary purpose of this initiative is to 
provide matching funds to assist in the acquisition of and/or 
significant upgrades to dedicated clinical research imaging equipment 
(software and/or hardware), in order to optimize the use of imaging as a 
biomarker in Phase 1 and 2 oncologic trials. It is strongly encouraged 
that the Principal Investigator (PI) identify a Co-PI affiliated with 
the cancer center who has clinical or technical competence with the 
proposed instrument for clinical oncology trials. The initiative is part 
of a continuing effort to stimulate and strengthen the use of imaging 
techniques in cancer research. NCI-funded cancer centers possess the 
infrastructure, organization, leadership, and integrated 
multidisciplinary research objectives that enable them to build and 
incorporate new imaging technologies into cancer clinical trials.  

NCI staff will contact the current grantees directly regarding 
application procedures and format.

INQUIRIES

For further information, contact:

Guoying Liu, Ph.D.
Program Director
National Cancer Institute
6130 Executive Boulevard
Executive Plaza North Suite 6000, MSC 7412
Bethesda, MD 20892-7412
Phone: 301-496-9531
Fax: 301-480-3507
Email: liug@mail.nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®